Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oriol Bestard

Showing results (81-90 of 172) with videos related to

Pageof 18
Sort By:
Neurology and Therapy|May 10, 2024
Safety, Tolerability, and Outcomes of Tafamidis for the Treatment of Acquired Amyloid Neuropathy in Domino Liver Transplant RecipientsVelina Nedkova-Hristova, Laura Donadeu, Carmen Baliellas, et al.
Nefrologia|December 7, 2025
Experience with new anti-CD20 monoclonal antibodies for immune-mediated glomerulopathies in a tertiary hospitalJorge Iván Zamora, Marina López-Martínez, Natalia Ramos, et al.
Clinical Pharmacokinetics|November 22, 2017
Prediction of Free from Total Mycophenolic Acid Concentrations in Stable Renal Transplant Patients: A Population-Based ApproachHelena Colom, Franc Andreu, Teun van Gelder, et al.
Clinical Kidney Journal|March 19, 2024
Transient acute kidney injury after chimeric antigen receptor T-cell therapy in patients with hematological malignanciesJuan León-Román, Gloria Iacoboni, Sheila Bermejo, et al.
Plos One|June 27, 2013
CD40 gene silencing reduces the progression of experimental lupus nephritis modulating local milieu and systemic mechanismsÈlia Ripoll, Ana Merino, Immaculada Herrero-Fresneda, et al.
Clinical Pharmacokinetics|May 4, 2023
Comparison of Three Renal Function Formulas for Ganciclovir/Valganciclovir Dose Individualization in CMV-Infected Solid Organ Transplantation Patients Using a Population ApproachPanagiotis Nikolaos Lalagkas, Jorge Iliou, Raul Rigo, et al.
Nefrologia|February 12, 2026
Fibrillary glomerulonephritis: clinicopathological characteristics and treatment in a spanish tertiary centerEfraín Tatis, Natalia Ramos Terrades, María Alejandra Gabaldón, et al.
Journal of the American Society of Nephrology : JASN|December 20, 2017
Dynamic Prognostic Score to Predict Kidney Allograft Survival in Patients with Antibody-Mediated RejectionDenis Viglietti, Alexandre Loupy, Olivier Aubert, et al.
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|September 15, 2012
Impact of small molecules immunosuppressants on P-glycoprotein activity and T-cell functionInés Llaudó, Linda Cassis, Joan Torras, et al.
Frontiers in Pharmacology|May 14, 2023
Immunosuppressant drugs and quality-of-life outcomes in kidney transplant recipients: An international cohort study (EU-TRAIN)François R Girardin, Anna Nicolet, Oriol Bestard, et al.
Pageof 18

Showing results (81-90 of 172) with videos related to

Sort By:
Pageof 18
Neurology and Therapy|May 10, 2024
Safety, Tolerability, and Outcomes of Tafamidis for the Treatment of Acquired Amyloid Neuropathy in Domino Liver Transplant RecipientsVelina Nedkova-Hristova, Laura Donadeu, Carmen Baliellas, et al.
Nefrologia|December 7, 2025
Experience with new anti-CD20 monoclonal antibodies for immune-mediated glomerulopathies in a tertiary hospitalJorge Iván Zamora, Marina López-Martínez, Natalia Ramos, et al.
Clinical Pharmacokinetics|November 22, 2017
Prediction of Free from Total Mycophenolic Acid Concentrations in Stable Renal Transplant Patients: A Population-Based ApproachHelena Colom, Franc Andreu, Teun van Gelder, et al.
Clinical Kidney Journal|March 19, 2024
Transient acute kidney injury after chimeric antigen receptor T-cell therapy in patients with hematological malignanciesJuan León-Román, Gloria Iacoboni, Sheila Bermejo, et al.
Plos One|June 27, 2013
CD40 gene silencing reduces the progression of experimental lupus nephritis modulating local milieu and systemic mechanismsÈlia Ripoll, Ana Merino, Immaculada Herrero-Fresneda, et al.
Clinical Pharmacokinetics|May 4, 2023
Comparison of Three Renal Function Formulas for Ganciclovir/Valganciclovir Dose Individualization in CMV-Infected Solid Organ Transplantation Patients Using a Population ApproachPanagiotis Nikolaos Lalagkas, Jorge Iliou, Raul Rigo, et al.
Nefrologia|February 12, 2026
Fibrillary glomerulonephritis: clinicopathological characteristics and treatment in a spanish tertiary centerEfraín Tatis, Natalia Ramos Terrades, María Alejandra Gabaldón, et al.
Journal of the American Society of Nephrology : JASN|December 20, 2017
Dynamic Prognostic Score to Predict Kidney Allograft Survival in Patients with Antibody-Mediated RejectionDenis Viglietti, Alexandre Loupy, Olivier Aubert, et al.
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|September 15, 2012
Impact of small molecules immunosuppressants on P-glycoprotein activity and T-cell functionInés Llaudó, Linda Cassis, Joan Torras, et al.
Frontiers in Pharmacology|May 14, 2023
Immunosuppressant drugs and quality-of-life outcomes in kidney transplant recipients: An international cohort study (EU-TRAIN)François R Girardin, Anna Nicolet, Oriol Bestard, et al.
Pageof 18